Actively Recruiting
Early Phase I Study of 68GaGa-FAPI-04 PETCT Scan in Adults with High-Grade Neuroendocrine Tumors
Led by University of Michigan Rogel Cancer Center · Updated on 2026-07-31
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the behavior and distribution of the tracer 68Ga Ga-FAPI-04 in patients with high-grade neuroendocrine tumors. This early phase I trial aims to determine how and where this tracer accumulates in both normal and cancerous tissues. The study uses PETCT imaging techniques to visualize the tracer, with PET detecting radioactivity from the tracer and CT providing detailed images of organs and affected tissues.
CONDITIONS
Brief Title
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
